raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:686999

Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome

Synonyms: PLAAT3-related lipodystrophy syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Status
active

A rare primary lipodystrophy characterized by partial to generalized loss of fat, associated with metabolic complications and variable neurological manifestations. Most patients present with lipoatrophy of the limbs and trunk, associated with muscular hypertrophy. Metabolic complications include insulin-resistant diabetes mellitus, hypertriglyceridemia, and hepatic steatosis. Major neurological involvement is characterized by demyelinating polyneuropathy. Intellectual disability has also been reported in some patients. Females may present with hirsutism, hyperandrogenism, and polycystic ovary syndrome, while males present with gynecomastia.

1

Names in Orphadata languages

9 of 12 languages
LangNameSynonyms
enLipodystrophy-demyelinating peripheral sensory-motor neuropathy syndromePLAAT3-related lipodystrophy syndrome
frSyndrome de lipodystrophie-neuropathie périphérique sensitivo-motrice démyélinisanteSyndrome de lipodystrophie associé à PLAAT3
deLipodystrophie-demyelinisierende periphere sensomotorische Neuropathie-SyndromLipodystrophie, familiäre partielle, Typ 9 · Lipodystrophie-Syndrom, PLAAT3-assoziiertes
esSíndrome de lipodistrofia-neuropatía periférica sensitivo-motora desmielinizanteSíndrome de lipodistrofia asociada a PLAAT3
itSindrome lipodistrofia-neuropatia sensitivo-motoria periferica demielinizzanteSindrome da lipodistrofia correlata a PLAAT3
nlLipodystrofie - demyeliniserende perifere sensorimotorische neuropathie-syndroomPLAAT3-gerelateerde lipodystrofie-syndroom
ptSíndrome de lipodistrofia-neuropatia desmielinizante sensitivo-motora periféricaSíndrome de lipodistrofia PLAAT3-relacionada
plZespół lipodystrofii i obwodowej demielinizacyjnej neuropatii czuciowo-ruchowej= en
csSyndrom zahrnující lipodystrofii a demyelinizační periferní senzoricko-motorickou neuropatii= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM620683Evalidated
MONDO958034Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PLAAT3Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:17825ENSG0000017648561386711q12.3-q13.1phospholipase A and acyltransferase 337919452[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families7 casesWorldwideCase(s)Validated37919452[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidated37919452[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card